Ligand validation:5XAG

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5XAG_GOL_A_503	34%	87%	0.208	0.89	0.36	0.33	-	-	0	0	100%	1
5XAG_GOL_C_506	24%	71%	0.229	0.856	0.54	0.57	-	-	1	0	100%	1
5XAG_GOL_C_504	23%	82%	0.231	0.854	0.31	0.48	-	-	0	0	100%	1
5XAG_GOL_D_504	11%	88%	0.307	0.826	0.36	0.3	-	-	0	0	100%	1
5XAG_GOL_A_506	8%	83%	0.261	0.743	0.38	0.4	-	-	1	0	100%	1
5XAG_GOL_C_501	6%	88%	0.357	0.802	0.36	0.31	-	-	1	0	100%	1
5XAG_GOL_B_503	3%	91%	0.374	0.707	0.36	0.23	-	-	0	0	100%	1
5XAG_GOL_B_504	3%	78%	0.378	0.698	0.45	0.43	-	-	0	0	100%	1
5XAG_GOL_D_503	1%	86%	0.571	0.659	0.33	0.38	-	-	2	0	100%	1
5XAG_GOL_A_504	0%	71%	0.451	0.499	0.41	0.7	-	-	0	0	100%	1
5XAG_GOL_C_505	0%	93%	0.743	0.736	0.42	0.09	-	-	0	0	100%	1
5XAG_GOL_B_505	0%	75%	0.771	0.577	0.38	0.58	-	-	6	0	100%	1
5EYP_GOL_F_201	85%	97%	0.108	0.972	0.05	0.27	-	-	0	0	100%	1
5BMV_GOL_A_505	61%	59%	0.131	0.921	0.45	1.09	-	-	0	0	100%	1
9F07_GOL_B_504	58%	97%	0.114	0.892	0.07	0.23	-	-	1	0	100%	1
8WMU_GOL_A_504	51%	47%	0.138	0.89	0.77	1.26	-	1	0	0	100%	0.821
5OSK_GOL_C_503	50%	89%	0.158	0.91	0.36	0.27	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.